Arcus Biosciences (RCUS) Revenue (2017 - 2026)
Arcus Biosciences (RCUS) posted Revenue of $41 million for Q2 2026, down 74.4% from $160 million a year earlier but up 141.2% from the prior quarter.
Arcus Biosciences (RCUS) Revenue (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Revenue at Arcus Biosciences was $117 million, down 55.3% year-over-year; for FY2025, it came in at $247 million, down 4.3% from FY2024.
- Annual Revenue shows a five-year compound annual growth rate of 25.9% (FY2020 to FY2025).
- In prior years, Arcus Biosciences' Revenue was $258 million in FY2024 (+120.5%), $117 million in FY2023 (+4.5%), $112 million in FY2022 (-70.8%) and $383 million in FY2021 (+391.0%).
- Quarterly Revenue has run from a low of $9.46 million in Q3 2021 to a high of $354.62 million in Q4 2021 over five years.
- On a year-over-year basis, Revenue increased in three of the last eight quarters, with growth averaging 16.4%.
- The strongest year-over-year quarter for Revenue in the past five years was Q1 2024, with growth of 480.0%; the weakest was Q4 2022, with a decline of 90.4%.
- According to Business Quant data, Revenue for the three prior quarters was $17 million (Q1 2026), $33 million (Q4 2025) and $26 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Arcus Biosciences | 3.18 Bn | -157.19 Mn | - | 41.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.00 Mn |
| Mar 31, 2026 | 17.00 Mn |
| Dec 31, 2025 | 33.00 Mn |
| Sep 30, 2025 | 26.00 Mn |
| Jun 30, 2025 | 160.00 Mn |
| Mar 31, 2025 | 28.00 Mn |
| Dec 31, 2024 | 26.00 Mn |
| Sep 30, 2024 | 48.00 Mn |
| Jun 30, 2024 | 39.00 Mn |
| Mar 31, 2024 | 145.00 Mn |
| Dec 31, 2023 | 31.00 Mn |
| Sep 30, 2023 | 32.00 Mn |
| Jun 30, 2023 | 29.00 Mn |
| Mar 31, 2023 | 25.00 Mn |
| Dec 31, 2022 | 34.00 Mn |
| Sep 30, 2022 | 33.00 Mn |
| Jun 30, 2022 | 27.00 Mn |
| Mar 31, 2022 | 18.00 Mn |
| Dec 31, 2021 | 354.62 Mn |
| Sep 30, 2021 | 9.46 Mn |
Arcus Biosciences Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=RCUS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();